Molecular Genetic Monitoring and Digital Transformation Technologies in Modern Epidemiology

封面

如何引用文章

全文:

详细

The pandemic of a new coronavirus infection has become a serious challenge for the health system of all countries, so as of May 2023, 766 million confirmed cases of the disease and more than 6.9 million deaths have been registered in the world. More than 22 million cases and 398 thousand deaths from a new coronavirus infection have been registered in the Russian Federation. The rapidly changing epidemiological situation necessitated the systematization of the material for analytical work. The need to create special tools for aggregating an array of heterogeneous information has become obvious. The high rate of accumulation of mutations in the genome of the pathogen made it necessary to study circulating genovariants both from the standpoint of their escape from postmorbid and postvaccinal immunity, and from the point of view of the characteristics of the epidemic process caused by individual variants of the virus and their significance for practical health care and the organization of antiepidemic measures. The significant heterogeneity in terms of population density, geographical and economic conditions of the constituent entities of the Russian Federation necessitated the organization of work on the implementation of continuous molecular genetic monitoring of the variability of the COVID-19 pathogen. The active development of computing technologies and the challenges faced by the epidemiological surveillance system during the COVID-19 pandemic created the prerequisites for the rapid development of the process of digital transformation in epidemiology. Three platforms were created on the basis of Central Research Institute of Epidemiologythe Russian data aggregation system VGARus, SOLAR and an analytical platform for analyzing the epidemiological situation regarding the new coronavirus infection based on the Superset program, which were the main tools for epidemiological monitoring of the new coronavirus infection.

作者简介

Vasily G. Akimkin

Central Research Institute of Epidemiology

Email: vgakimkin@yandex.ru
ORCID iD: 0000-0003-4228-9044
SPIN 代码: 4038-7455

MD, PhD, Professor, Academician of the RAS

俄罗斯联邦, 3a Novogireevskaya Str., Moscow, 111123

Kamil Khafizov

Central Research Institute of Epidemiology

Email: khafizov@cmd.su
ORCID iD: 0000-0001-5524-0296
SPIN 代码: 9082-5749

PhD in Biology

俄罗斯联邦, 3a Novogireevskaya Str., Moscow, 111123

Dmitry Dubodelov

Central Research Institute of Epidemiology

Email: dubodelov@cmd.su
ORCID iD: 0000-0003-3093-5731
SPIN 代码: 4860-7909

MD, PhD, Senior Research Associate

俄罗斯联邦, 3a Novogireevskaya Str., Moscow, 111123

Evgeny Voronin

Central Research Institute of Epidemiology

Email: emvoronin@yandex.ru
ORCID iD: 0000-0001-5925-7757
SPIN 代码: 8153-8179
俄罗斯联邦, 3a Novogireevskaya Str., Moscow, 111123

Anna Cherkashina

Central Research Institute of Epidemiology

Email: cherkashina@pcr.ms
ORCID iD: 0000-0001-7970-7495
SPIN 代码: 7854-7358

 PhD in Chemistry

俄罗斯联邦, 3a Novogireevskaya Str., Moscow, 111123

Svetlana Ugleva

Central Research Institute of Epidemiology

编辑信件的主要联系方式.
Email: uglevas@bk.ru
ORCID iD: 0000-0002-1322-0155
SPIN 代码: 8840-5814

MD, PhD, Professor

俄罗斯联邦, 3a Novogireevskaya Str., Moscow, 111123

Denis Stratulat

Central Research Institute of Epidemiology

Email: stratylat@cmd.su
ORCID iD: 0000-0003-0988-4466
俄罗斯联邦, 3a Novogireevskaya Str., Moscow, 111123

Alexander Samsonov

Central Research Institute of Epidemiology

Email: samsonov@cmd.su
ORCID iD: 0009-0007-8036-1883
俄罗斯联邦, 3a Novogireevskaya Str., Moscow, 111123

参考

  1. Weekly epidemiological update on COVID-19 — 18 May 2023. Ed. 143. Availanle online: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---18-may-2023. Accessed on August 30, 2023.
  2. Акимкин В.Г., Семененко Т.А., Углева С.В. и др. COVID-19 в России: эпидемиология и молекулярно-генетический мониторинг // Вестник РАМН. — 2022. — Т. 77. — № 4. — С. 254–260. — doi: https://doi.org/10.15690/vramn2121 [Akimkin VG, Semenenko TA, Ugleva SV, et al. COVID-19 in Russia: epidemiology and molecular genetic monitoring. Annals of the Russian Academy of Medical Sciences. 2022;77(4):254–260. (In Russ).] doi: https://doi.org/10.15690/vramn2121
  3. Ступак В.С., Зубко А.В., Маношкина Е.М. и др. Здравоохранение России в период пандемии COVID-19: вызовы, системные проблемы и решение первоочередных задач // Профилактическая медицина. — 2022. — Т. 25. — № 11. — С. 21–27. — doi: https://doi.org/10.17116/profmed20222511121 [Stupak VS, Zubko AV, Manoshkina EM, et al. Healthcare in Russia during the COVID-19 pandemic: challenges, systemic issues, and addressing priorities. Profilakticheskaya Meditsina. 2022;25(11):21–27. (In Russ).] doi: https://doi.org/10.17116/profmed20222511121
  4. Hill V, Ruis C, Bajaj S, et al. Progress and challenges in virus genomic epidemiology. Trends Parasitol. 2021;37(12):1038–1049. doi: 10.1016/j.pt.2021.08.007
  5. Attwood SW, Hill SC, Aanensen DM, et al. Phylogenetic and phylodynamic approaches to understanding and combating the early SARS-CoV-2 pandemic. Nat Rev Genet. 2022;23(9):547–562. doi: https://doi.org/10.1038/s41576-022-00483-8
  6. Khare S, Gurry C, Freitas L, et al. GISAID’s Role in Pandemic Response. China CDC Weekly. 2021;3(49):1049–1051. doi: https://doi.org/10.46234/ccdcw2021.255
  7. Catlin T, Lorenz JT, Sternfels B, Willmott P. A Roadmap for a Digital Transformation. In: McKinsey & Company. March 2017. Available online: https://www.mskinsey.com/industies/financial-services/our-insights/aroadmap-for-a-digital-transformation. Accessed on August 30, 2023.
  8. Digital, Technology, and Data. In: Boston Consulting Group. 2023. Available online: https://www.bcg.com/en-us/digital-bcg/overview.aspx. Accessed on August 30, 2023.
  9. Laney D. 3D Data Management: Controlling Data Volume, Velocity and Variety. META Group. February 6, 2001. 4 p. Available online: https://studylib.net/doc/8647594/3d-data-management--controlling-data-volume--velocity--an... Accessed on August 30, 2023.
  10. ГОСТ Р ИСО/МЭК 20546-2021. Национальный стандарт Российской Федерации. Информационные технологии. Большие данные. Обзор и словарь. [All-Union State Standard Р ИСО/МЭК 20546-2021. National standard of the Russian Federation. Information technology. Big data. Overview and vocabulary. (In Russ).]
  11. ГОСТ 33707-2016 (ISO/IEC 2382:2015). Межгосударственный стандарт. Информационные технологии. Словарь. [All-Union State Standard 33707-2016 (ISO/IEC 2382:2015). Interstate standard. Information technologies. Vocabulary. (In Russ).]
  12. ГОСТ ISO/IEC 17788-2016. Межгосударственный стандарт. Информационные технологии. Облачные вычисления. Общие положения и терминология. [All-Union State Standard ISO/IEC 17788-2016. Interstate standard. Information technology. Cloud computing. Overview and vocabulary. (In Russ).]
  13. ГОСТ Р 59895-2021. Национальный стандарт Российской Федерации. Технологии искусственного интеллекта в образовании. Общие положения и терминология. [All-Union State Standard Р 59895-2021. National standard of the Russian Federation. Artificial intelligence technologies in education. General provisions and terminology. (In Russ).]
  14. Акимкин В.Г., Попова А.Ю., Плоскирева А.А. и др. COVID-19: эволюция пандемии в России. Сообщение I: проявления эпидемического процесса COVID-19 // Журнал микробиологии, эпидемиологии и иммунобиологии. — 2022. — Т. 99. — № 3. — С. 269–286. doi: https://doi.org/10.36233/0372-9311-276 [Akimkin VG, Popova AYu, Ploskireva AA, et al. COVID-19: the evolution of the pandemic in Russia. Report I: manifestations of the COVID-19 epidemic process. Journal of microbiology, epidemiology and immunobiology = Zhurnal mikrobiologii, epidemiologii i immunobiologii. 2022;99(3):269-286. (In Russ).] doi: https://doi.org/10.36233/0372-9311-276
  15. Акимкин В.Г., Попова А.Ю., Хафизов К.Ф. и др. COVID-19: эволюция пандемии в России. Сообщение II: динамика циркуляции геновариантов вируса SARS-CoV-2 // Журнал микробиологии, эпидемиологии и иммунобиологии. — 2022. — Т. 99. — № 4. — С. 381–396. — doi: https://doi.org/10.36233/0372-9311-295 [Akimkin VG, Popova AYu, Khafizov KF, et al. COVID-19: evolution of the pandemic in Russia. Report II: dynamics of the circulation of SARS-CoV-2 genetic variants. Journal of microbiology, epidemiology and immunobiology = Zhurnal mikrobiologii, epidemiologii i immunobiologii. 2022;99(4):381–396. (In Russ).] doi: https://doi.org/10.36233/0372-9311-295
  16. Meyerowitz EA, Richterman A, Gandhi RT, Sax PE. Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors. Ann Intern Med. 2021;174(1):69–79. doi: https://doi.org/10.7326/M20-5008
  17. O’Toole Á, Pybus OG, Abram ME, et al. Pango lineage designation and assignment using SARS-CoV-2 spike gene nucleotide sequences. BMC Genomics. 2022;23(1):121. doi: https://doi.org/10.1186/s12864-022-08358-2
  18. Хорошун Д.К., Момыналиев К.Т., Воронин Е.М., Акимкин В.Г. Анализ поисковых запросов в «Яндекс», связанных с COVID-19 в Российской Федерации // Медицинский алфавит. — 2022. — № 18. — С. 14–22. doi: https://doi.org/10.33667/2078-5631-2022-18-14-22 [Khoroshun DK, Momynaliev KТ, Voronin EM, Akimkin VG. Analysis of Yandex search queries related to COVID-19 in Russian Federation. Medical alphabet. 2022;(18):14–22. (In Russ).] doi: https://doi.org/10.33667/2078-5631-2022-18-14-22
  19. Акимкин В.Г., Тутельян А.В., Шулакова Н.И., Воронин Е.М. Пандемия COVID-19: новый виток нарастания антибиотикорезистентности // Инфекционные болезни. — 2021. — Т. 19. — № 3. — С. 133–138. — doi: https://doi.org/10.20953/1729-9225-2021-3-133-138 [Akimkin VG, Tutelyan AV, Shulakova NI, Voronin EM. Пандемия COVID-19 pandemic: a new round of antibiotic resistance. Infectious diseases. 2021;19(3):133–138. (In Russ).] doi: https://doi.org/10.20953/1729-9225-2021-3-133-138

补充文件

附件文件
动作
1. JATS XML

版权所有 © "Paediatrician" Publishers LLC, 2023

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).